Estimate Recalculated Apr 10, 2025 08:46PM EST
Herbert J Conrad has an estimated net worth of $5.73 Million. This is based on reported shares across multiple companies, which include SAVIENT PHARMACEUTICALS INC, TEKMIRA PHARMACEUTICALS CORP, Celldex Therapeutics, Inc., Matinas BioPharma Holdings, Inc., Pharmasset Inc, and BONE CARE INTERNATIONAL INC.
Herbert J Conrad's CIK is 0001218815
2007 was Herbert J Conrad's most active year for acquiring shares with 15 total transactions. Herbert J Conrad's most active month to acquire stocks was the month of May. 2007 was Herbert J Conrad's most active year for disposing of shares, totalling 22 transactions. Herbert J Conrad's most active month to dispose stocks was the month of September. 2004 saw Herbert J Conrad paying a total of $551,093.93 for 44,673 shares, this is the most they've acquired in one year. In 2005 Herbert J Conrad cashed out on 103,424 shares for a total of $2,286,768.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!